NO308126B1 - Fosfolipidbasert forbindelse, anvendelse derav samt røntgenkontrastmiddel - Google Patents

Fosfolipidbasert forbindelse, anvendelse derav samt røntgenkontrastmiddel

Info

Publication number
NO308126B1
NO308126B1 NO934383A NO934383A NO308126B1 NO 308126 B1 NO308126 B1 NO 308126B1 NO 934383 A NO934383 A NO 934383A NO 934383 A NO934383 A NO 934383A NO 308126 B1 NO308126 B1 NO 308126B1
Authority
NO
Norway
Prior art keywords
based compound
contrast agent
pct
ray contrast
phospholipid
Prior art date
Application number
NO934383A
Other languages
English (en)
Norwegian (no)
Other versions
NO934383L (no
NO934383D0 (no
Inventor
Bengt Hersloef
Kore Larsson
Stig Bengmark
Original Assignee
Karlshamns Lipidteknik Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karlshamns Lipidteknik Ab filed Critical Karlshamns Lipidteknik Ab
Publication of NO934383L publication Critical patent/NO934383L/no
Publication of NO934383D0 publication Critical patent/NO934383D0/no
Publication of NO308126B1 publication Critical patent/NO308126B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A61K49/0466—Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Tires In General (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO934383A 1991-06-03 1993-12-02 Fosfolipidbasert forbindelse, anvendelse derav samt røntgenkontrastmiddel NO308126B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9101709A SE9101709L (sv) 1991-06-03 1991-06-03 Lipidderivat som diagnostikum eller kontrastmedel
PCT/SE1992/000374 WO1992021384A1 (en) 1991-06-03 1992-06-03 X-ray contrast agent

Publications (3)

Publication Number Publication Date
NO934383L NO934383L (no) 1993-12-02
NO934383D0 NO934383D0 (no) 1993-12-02
NO308126B1 true NO308126B1 (no) 2000-07-31

Family

ID=20382938

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934383A NO308126B1 (no) 1991-06-03 1993-12-02 Fosfolipidbasert forbindelse, anvendelse derav samt røntgenkontrastmiddel

Country Status (13)

Country Link
US (1) US5550263A (de)
EP (1) EP0588869B1 (de)
JP (1) JP3013939B2 (de)
AT (1) ATE185490T1 (de)
AU (1) AU652260B2 (de)
CA (1) CA2103462C (de)
DE (1) DE69230144T2 (de)
DK (1) DK0588869T3 (de)
ES (1) ES2140409T3 (de)
FI (1) FI935386A (de)
NO (1) NO308126B1 (de)
SE (1) SE9101709L (de)
WO (1) WO1992021384A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE470086B (sv) * 1991-04-23 1993-11-08 Kabi Pharmacia Ab Organspecifik emulsion
US6217849B1 (en) * 1993-09-29 2001-04-17 Bracco Research S.A. Liposome suspensions as blood pool imaging contrast agents
US5851510A (en) * 1994-05-16 1998-12-22 The Board Of Regents Of The University Of Michigan Hepatocyte-selective oil-in-water emulsion
GB9420390D0 (en) * 1994-10-10 1994-11-23 Nycomed Salutar Inc Liposomal agents
AU5260301A (en) * 2000-04-28 2001-11-12 Fuji Photo Film Co Ltd Liposomes containing hydrophobic iodo compound
US7008614B2 (en) * 2001-08-20 2006-03-07 Fuji Photo Film Co., Ltd. Liposome containing hydrophobic iodine compound and X-ray contrast medium for radiograph comprising the liposome
US20040018237A1 (en) 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
US7498018B2 (en) * 2003-10-03 2009-03-03 Bracco Diagnostics Inc. Contrast media for use in medical and diagnostic procedures and methods of using the same
DE102004049652A1 (de) * 2004-10-11 2006-04-20 Degussa Ag Leitungssystem für Fluide und Gase in einer Brennstoffzelle
WO2007129311A2 (en) * 2006-05-04 2007-11-15 Pan Sci Tech S.A. Nano-particles with contrast agents for diagnostic delivery system for x-ray and ct
CA2830298C (en) 2011-03-17 2016-08-16 Transdermal Biotechnology, Inc. Topical nitric oxide systems comprising lecithin and methods of use thereof
EP2532649B1 (de) * 2011-06-07 2015-04-08 Incella GmbH Aminolipide, deren Synthese und Verwendungen davon
WO2013121284A1 (en) * 2012-02-14 2013-08-22 Universite De Strasbourg Iodinated products intended for a use for the medical imaging and their methods of preparation
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
CN105142680A (zh) * 2013-03-15 2015-12-09 加利福尼亚大学董事会 基于低-z原子的肠ct造影材料

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235792A (en) * 1977-04-14 1980-11-25 The Governing Council Of The University Of Toronto Immunological materials
US4192859A (en) * 1978-09-29 1980-03-11 E. R. Squibb & Sons, Inc. Contrast media containing liposomes as carriers
CH641682A5 (en) * 1978-10-05 1984-03-15 Daeniker Felix X-ray contrast medium
US4386078A (en) * 1980-03-03 1983-05-31 The Ohio State University Research Foundation Therapeutic agents for preventing phospholipid degradation and free fatty acid proliferation
US4480041A (en) * 1982-07-09 1984-10-30 Collaborative Research, Inc. Use of phosphotriester intermediates for preparation of functionalized liposomes
JPS59187792A (ja) * 1983-04-11 1984-10-24 Meito Sangyo Kk 酵素法リン脂質糖類誘導体の製法
DE3778626D1 (de) * 1986-09-27 1992-06-04 Toyo Jozo Kk Nukleosid-phospholipid-konjugat.
JPS63233374A (ja) * 1987-03-20 1988-09-29 Tohoku Denshi Sangyo Kk 過酸化脂質の測定方法およびその測定装置
CH672733A5 (de) * 1987-05-22 1989-12-29 Bracco Ind Chimica Spa
CA1340413C (en) * 1987-09-09 1999-03-02 Chiron Diagnostics Corporation Method of preparing phosphodiester conjugates useful for immunoactive liposomes

Also Published As

Publication number Publication date
JP3013939B2 (ja) 2000-02-28
FI935386A0 (fi) 1993-12-01
CA2103462C (en) 1998-03-31
ATE185490T1 (de) 1999-10-15
EP0588869A1 (de) 1994-03-30
NO934383L (no) 1993-12-02
CA2103462A1 (en) 1992-12-04
SE9101709D0 (sv) 1991-06-03
JPH06510276A (ja) 1994-11-17
ES2140409T3 (es) 2000-03-01
DK0588869T3 (da) 2000-04-17
AU1903392A (en) 1993-01-08
FI935386A (fi) 1993-12-01
SE9101709L (sv) 1992-12-04
AU652260B2 (en) 1994-08-18
NO934383D0 (no) 1993-12-02
US5550263A (en) 1996-08-27
EP0588869B1 (de) 1999-10-13
DE69230144D1 (de) 1999-11-18
DE69230144T2 (de) 2000-05-25
WO1992021384A1 (en) 1992-12-10

Similar Documents

Publication Publication Date Title
NO308126B1 (no) Fosfolipidbasert forbindelse, anvendelse derav samt røntgenkontrastmiddel
ES2136723T3 (es) Utilizacion de n-aril-metilen-etilen-diamino-triacetatos, n-aril-metilen-imino-diacetatos o n,n'-diaril-metilen-etilen-diamino-acetatos contra el estres oxidante.
PL310171A1 (en) Novel imidazopyridines
EP0517024A3 (en) Tetravalent bispecific receptors, their preparation and use
HUT51863A (de)
DE69329256T2 (de) Kompensation von Nachleuchtzeit aus den vorhergehenden Computertomographieabtastungen
EP0369262A3 (de) Pyrrol-Derivate
ES2086771T3 (es) Composicion dermatologica y/o cosmetologica que contiene retinoides.
ES2172600T3 (es) Composicion farmaceutica que comprende lamotrigina.
ES2134768T3 (es) Composicion farmaceutica que comprende un fosfoazucar.
JPS56501092A (de)
FI962299A0 (fi) Hirudiinista ja lipofiilisistä yhdisteistä muodostuneet hirudiini-konjugaatit
ES2096099T3 (es) Perhidro-1h-pirido(1,2,a)pirazinas 2-sustituidas neurolepticas.
FR2726271B1 (fr) Derives de 6-polyfluoroalcoxy-2-aminobenzothiazole
KR880009644A (ko) 궤양성 대장질환 치료용 약한 조성물
FI933231A (fi) Acylaminoalkylidenhydroxibisfosfonsyror anvaendningsbara vid terapi av benledsjukdomar
IL67272A (en) Alkylcycloalkyl imidazolylmethyl ketones and their preparation
KR960700053A (ko) 방사선회복제로서 리루졸의 이용(application of riluzole as a radiorestorer)
UA23368A (uk) Використання (1,1-діоксотіолан-3-іл) диктіокарбамату калію як антимікробного засобу

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN DECEMBER 2001